Drugs That Can Increase Lactate
Metformin is the most clinically significant drug that increases lactate risk, particularly in patients with renal impairment (eGFR <30 mL/min/1.73 m²), acute illness, sepsis, hypoxia, liver failure, or during procedures requiring contrast. 1, 2
Primary High-Risk Medications
Metformin (Most Common)
Risk factors for lactic acidosis:
- eGFR <30 mL/min/1.73 m² (absolute contraindication) 3, 1, 2
- Acute kidney injury, dehydration, or shock 1
- Sepsis, hypoxia, or conditions causing anaerobic metabolism 1
- Liver failure (impaired lactate clearance) 1
- Acute heart failure 1
- Before iodinated contrast procedures in patients with eGFR <60 mL/min/1.73 m² 1
Management approach:
Linezolid
- Second most reported medication for lactic acidosis after metformin (815 cases in FAERS database) 5
- Can cause life-threatening lactic acidosis requiring drug discontinuation 6
- Monitor for metabolic problems and bone marrow suppression 3
Beta-Agonists
- Epinephrine and albuterol are among the most commonly identified agents causing medication-induced lactate elevation 7
- Mechanism: increased aerobic glycolysis and cellular metabolic stress 7
Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
- Stavudine, didanosine, zidovudine 3, 6
- Well-established pathophysiology for lactic acidosis 7
- Mitochondrial toxicity leading to impaired oxidative phosphorylation 6
Additional Medications With Lactate Risk
Cardiovascular Agents
Other Antidiabetic Agents
- Sulfonylureas - primarily cause hypoglycemia rather than direct lactate elevation, but hypoglycemia can trigger stress response 8, 1
Analgesics
Corticosteroids
- Dexamethasone - recently reported association with type B lactic acidosis even in stable ward patients 9
- Mechanism unclear but documented in critically ill patients 9
Antivirals (Systemic)
- 16 of the top 50 medications with strongest signal for lactic acidosis were systemic antivirals 5
Clinical Recognition Algorithm
When encountering unexplained lactate elevation:
Rule out Type A lactic acidosis first (tissue hypoperfusion):
- Sepsis, shock, hypotension
- Hypoxia, severe anemia
- Cardiac arrest, acute MI
If Type A excluded, perform medication review for Type B:
- Check all medications against high-risk list above
- Assess renal function (eGFR) for renally cleared drugs
- Evaluate hepatic function for drugs requiring hepatic metabolism
- Consider drug-drug interactions potentiating risk
Specific metformin assessment:
Management Priorities
Immediate actions when drug-induced lactic acidosis suspected:
- Discontinue the offending agent immediately 7, 10
- Provide aggressive supportive care (IV fluids, hemodynamic support)
- Consider continuous renal replacement therapy (CRRT) for severe cases, especially metformin-associated lactic acidosis with AKI 11
- Monitor lactate serially (should decline within 4-12 hours with CRRT) 11
- Address precipitating factors (infection, dehydration, renal dysfunction)
Critical Pitfalls to Avoid
- Do not overlook medication review in patients with baseline elevated lactate (e.g., liver metastases) who develop acute worsening 11
- Do not continue metformin during acute illness or "sick days" even if baseline renal function is adequate 4
- Do not assume lactic acidosis is only from metformin - 59 unique medications identified in systematic review 7
- 23 of top 50 high-risk medications lack lactic acidosis warning in their product labeling 5
- Mortality from medication-induced lactic acidosis ranges 6-16% in case series 7